NCT07477457 2026-03-17
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
Memorial Sloan Kettering Cancer Center
China Medical University Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Hunan Province Tumor Hospital